AHR vs VTR

For growth investors, Ventas, Inc.

(VTR) is the stronger pick with 18. 5% revenue growth year-over-year, versus 11. 4% for American Healthcare REIT, Inc. (AHR). Ventas, Inc. (VTR) offers the better valuation at 160. 4x trailing P/E (118. 1x forward), making it the more compelling value choice. Analysts rate American Healthcare REIT, Inc. (AHR) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, American Healthcare REIT, Inc.

is actually cheaper at 66. 5x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, American Healthcare REIT, Inc.

(AHR) delivered a total return of +295. 4%, compared to +77. 4% for Ventas, Inc. (VTR). Over 10 years, the gap is even starker: AHR returned +295. 4% versus VTR's +66. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Ventas, Inc.

(VTR) is the lower-risk stock at 0. 01β versus American Healthcare REIT, Inc. 's 0. 23β — meaning AHR is approximately 2304% more volatile than VTR relative to the S&P 500. On balance sheet safety, American Healthcare REIT, Inc. (AHR) carries a lower debt/equity ratio of 81% versus 105% for Ventas, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Ventas, Inc.

(VTR) is pulling ahead at 18. 5% versus 11. 4% for American Healthcare REIT, Inc. (AHR). On earnings-per-share growth, the picture is similar: Ventas, Inc. grew EPS 184. 2% year-over-year, compared to 73. 1% for American Healthcare REIT, Inc.. Over a 3-year CAGR, AHR leads at 17. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Ventas, Inc.

(VTR) is the more profitable company, earning 4. 3% net margin versus -1. 8% for American Healthcare REIT, Inc. — meaning it keeps 4. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: VTR leads at 14. 2% versus 6. 6% for AHR. At the gross margin level — before operating expenses — AHR leads at 20. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, American Healthcare REIT, Inc.

(AHR) trades at 66. 5x forward P/E versus 118. 1x for Ventas, Inc. — 51. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AHR: 13. 5% to $56. 75.

All stocks in this comparison pay dividends.

Ventas, Inc. (VTR) offers the highest yield at 2. 1%, versus 1. 9% for American Healthcare REIT, Inc. (AHR).

For long-horizon retirement investors, Ventas, Inc.

(VTR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 01), 2. 1% yield). Both have compounded well over 10 years (VTR: +66. 5%, AHR: +295. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: AHR is a small-cap quality compounder stock; VTR is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.